Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei JKT Bio-Pharmaceutical is a specialized pharmaceutical manufacturer based in China, focusing on the production of steroid hormone active pharmaceutical ingredients (APIs) and their intermediates. The company maintains a large-scale production facility in Tianmen, Hubei, where it utilizes advanced chemical synthesis and fermentation technologies. Their product portfolio includes key steroid derivatives such as progesterone, testosterone, and spironolactone, which are supplied to global pharmaceutical companies for various therapeutic applications. JKT Bio-Pharmaceutical operates under strict GMP guidelines to ensure the quality and safety of its products for the international market. The company serves as a critical link in the supply chain for endocrine and reproductive health medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei JKT BioPharma.